INVENTIVA SA - ADR Share Price Today: Live Updates & Key Insights

INVENTIVA SA - ADR share price today is $5.77, up -4.3%. The stock opened at $6 against the previous close of $6.04, with an intraday high of $6.06 and low of $5.66.

INVENTIVA SA - ADR Share Price Chart

INVENTIVA SA - ADR

us-stock
To Invest in {{usstockname}}
us-stock

INVENTIVA SA - ADR Share Price Performance

$5.77 -0.043(-4.3%) IVA at 23 Mar 2026 01:43 PM Biotechnology
Lowest Today 5.66
Highest Today 6.06
Today’s Open 6
Prev. Close 6.04
52 Week High 7.98
52 Week Low 2.70
Day’s Range: Low 5.66 High 6.06
52-Week Range: Low 2.70 High 7.98
1 day return -
1 Week return -4.83
1 month return -13.74
3 month return +33.14
6 month return -3.73
1 year return +97.44
3 year return +46.96
5 year return -60.44
10 year return -

INVENTIVA SA - ADR Institutional Holdings

Samsara BioCapital, LLC 2.52

Paradigm Biocapital Advisors LP 1.94

ADAR1 Capital Management LLC 1.31

Trails Edge Capital Partners, LP 1.29

Millennium Management LLC 1.29

Yiheng Capital LLC 1.28

SymBiosis Capital Partners, LLC 1.26

Caligan Partners LP 0.97

Polar Capital Holdings PLC 0.97

Polar Capital Biotech S Inc 0.92

Andera Partners 0.88

Franklin Biotechnology Discv A(acc)USD 0.77

Ally Bridge Group (NY) LLC 0.73

Yu Fan 0.73

NEA Management Company, LLC 0.71

NEXTBio Capital Management LP 0.63

RTW INVESTMENTS, LLC 0.63

Propel Bio Management LLC 0.48

Franklin Biotechnology Discovery A 0.44

Bvf Inc 0.33

BOOTHBAY FUND MANAGEMENT, LLC 0.32

J. Goldman & Co LP 0.25

Alyeska Investment Group, L.P. 0.24

Simplify Propel Opportunities ETF 0.12

Russell Inv US Small Cap Equity Y 0.02

Russell Inv Small Cap Fund F 0.01

Russell Inv Equity II 0.01

Russell Inv US Small Cap Equity 0.00

Fidelity Nasdaq Composite Index 0.00

INVENTIVA SA - ADR Market Status

Strong Buy: 6

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

INVENTIVA SA - ADR Fundamentals

Market Cap 557.31 M

PB Ratio 2.1025

PE Ratio 0.0

Enterprise Value 1135.15 M

Total Assets 118.97 M

Volume 351366

INVENTIVA SA - ADR Company Financials

Annual Revenue FY23:17477000 17.5M, FY22:12179000 12.2M, FY21:4194000 4.2M, FY20:372000 0.4M, FY19:6998000 7.0M

Annual Profit FY23:17500000 17.5M, FY22:12179000 12.2M, FY21:4194000 4.2M, FY20:372000 0.4M, FY19:6998000 7.0M

Annual Net worth FY23:-110426000 -110.4M, FY22:-54274000 -54.3M, FY21:-49636000 -49.6M, FY20:-31623000 -31.6M, FY19:-30221000 -30.2M

Quarterly Revenue Q2/2025:4454000 4.5M, Q1/2025:6464000 6.5M, Q3/2024:2734000 2.7M, Q2/2024:2734000 2.7M, Q1/2024:16541000 16.5M

Quarterly Profit Q2/2025:2750000 2.8M, Q1/2025:6990000 7.0M, Q3/2024:2734000 2.7M, Q2/2024:2734000 2.7M, Q1/2024:15983000 16.0M

Quarterly Net worth Q2/2025:-175882000 -175.9M, Q1/2025:-135183000 -135.2M, Q3/2024:-49029000 -49.0M, Q2/2024:-49029000 -49.0M, Q1/2024:-55157000 -55.2M

About INVENTIVA SA - ADR & investment objective

Company Information Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.

Organisation Biotechnology

Employees 84

Industry Biotechnology

CEO Mr. Andrew Obenshain

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

INVENTIVA SA - ADR FAQs

What is the share price of INVENTIVA SA - ADR today?

The current share price of INVENTIVA SA - ADR is $5.77.

Can I buy INVENTIVA SA - ADR shares in India?

Yes, Indian investors can buy INVENTIVA SA - ADR shares by opening an international trading and demat account with Motilal Oswal.

How to buy INVENTIVA SA - ADR shares in India?

You can easily invest in INVENTIVA SA - ADR shares from India by:

Can I buy fractional shares of INVENTIVA SA - ADR?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of INVENTIVA SA - ADR?

INVENTIVA SA - ADR has a market cap of $557.31 M.

In which sector does INVENTIVA SA - ADR belong?

INVENTIVA SA - ADR operates in the Biotechnology sector.

What documents are required to invest in INVENTIVA SA - ADR stocks?

To invest, you typically need:

What is the PE and PB ratio of INVENTIVA SA - ADR?

The PE ratio of INVENTIVA SA - ADR is N/A and the PB ratio is 2.10.